| REVIEW ARTICLE |
|
| Year : 2007 | Volume
: 4
| Issue : 1 | Page : 107-117 |
|
|
Management of severe acute hepatitis B
Sudeep Khanna, Rakesh Tandon
Department of Gastroenterology and Metabolic Disorders, Pushpawati Singhania Research Institute for Liver, Renal and Digestive Diseases, Sheikh Sarai, Phase II, Press Enclave Road, New Delhi-110 017, India
Correspondence Address:
Sudeep Khanna
Department of Gastroenterology and Metabolic Disorders, Pushpawati Singhania Research Institute for Liver, Renal and Digestive Diseases, Sheikh Sarai, Phase II, Press Enclave Road, New Delhi-110 017
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0972-9747.45092
|
|
|
HBV infection is a major public health problem. Acute viral hepatitis B is successfully cleared in more than 95% of immunocompetent patients. HBV infection can cause severe acute hepatitis which can progress to acute liver failure. The purpose of this review is to discuss the immune response in acute hepatitis B and the possible role of HBV genotypes in development of severe acute HBV related hepatitis, define severe acute hepatitis B and to look at the role of the available antivirals in this clinical setting. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
